Massachusetts Financial Services’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,055
Closed -$661K 860
2024
Q2
$661K Buy
8,055
+271
+3% +$29.3K ﹤0.01% 817
2024
Q1
$1.13M Sell
7,784
-18
-0.2% -$1.52K ﹤0.01% 778
2023
Q4
$719K Buy
+7,802
New +$793K ﹤0.01% 786

Other funds holding CDLX

Massachusetts Financial Services's CDLX Position: Q3 2024 in Review

Massachusetts Financial Services sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 8,055 shares — an estimated $661K sold.

Massachusetts Financial Services first reported a position in CDLX in Q4 2023 and held it in 3 quarters. The position peaked at $1.13M in Q1 2024. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • Massachusetts Financial Services reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 8,055 Cardlytics shares in Q3 2024, an estimated $661K.
  • Massachusetts Financial Services first reported a position in Cardlytics in Q4 2023 and held it in 3 quarters.
  • Massachusetts Financial Services's Cardlytics position peaked at $1.13M in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on Massachusetts Financial Services's 13F filing for Q3 2024, filed 12 Nov 2024.